PROGENICS PHARMACEUTICALS IN's ticker is PGNX and the CUSIP is 743187106. A total of 131 filers reported holding PROGENICS PHARMACEUTICALS IN in Q4 2019. The put-call ratio across all filers is 1.40 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $0 | – | 0 | – | 0.00% | – |
| Q1 2021 | $0 | – | 0 | – | 0.00% | – |
| Q4 2020 | $0 | – | 0 | – | 0.00% | – |
| Q3 2020 | $0 | – | 0 | – | 0.00% | – |
| Q2 2020 | $0 | – | 0 | – | 0.00% | – |
| Q1 2020 | $0 | -100.0% | 0 | -100.0% | 0.00% | – |
| Q4 2019 | $2,000 | 0.0% | 300 | 0.0% | 0.00% | – |
| Q3 2019 | $2,000 | +100.0% | 300 | -12.0% | 0.00% | – |
| Q4 2018 | $1,000 | -50.0% | 341 | 0.0% | 0.00% | – |
| Q3 2018 | $2,000 | -33.3% | 341 | 0.0% | 0.00% | – |
| Q2 2018 | $3,000 | +50.0% | 341 | 0.0% | 0.00% | – |
| Q1 2018 | $2,000 | 0.0% | 341 | 0.0% | 0.00% | – |
| Q4 2017 | $2,000 | -33.3% | 341 | -24.4% | 0.00% | – |
| Q3 2017 | $3,000 | 0.0% | 451 | 0.0% | 0.00% | – |
| Q2 2017 | $3,000 | -25.0% | 451 | 0.0% | 0.00% | – |
| Q1 2017 | $4,000 | 0.0% | 451 | 0.0% | 0.00% | – |
| Q4 2016 | $4,000 | +33.3% | 451 | +10.0% | 0.00% | – |
| Q3 2016 | $3,000 | +50.0% | 410 | 0.0% | 0.00% | – |
| Q2 2016 | $2,000 | -33.3% | 410 | 0.0% | 0.00% | – |
| Q4 2015 | $3,000 | – | 410 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|